Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-21

FDA Approved: EFAVIRENZ — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves Aurobindo Pharma Limited's generic efavirenz (original ANDA) for the treatment of HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

ORIG AP for EFAVIRENZ (EFAVIRENZ)